The Journal of Experimental Medicine
FluoroSpot from Mabtech
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online May 14, 2007
doi:10.1084/jem.20062512
The Journal of Experimental Medicine, Vol. 204, No. 6, 1257-1265
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Deaglio et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1466K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deaglio, S.
Right arrow Articles by Robson, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deaglio, S.
Right arrow Articles by Robson, S. C.
Related Collections
Right arrowRelated Articles
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

Silvia Deaglio1, Karen M. Dwyer1, Wenda Gao1, David Friedman1, Anny Usheva1, Anna Erat1, Jiang-Fan Chen3, Keiichii Enjyoji1, Joel Linden4, Mohamed Oukka5, Vijay K. Kuchroo5, Terry B. Strom1,2, and Simon C. Robson1

1 Department of Medicine and 2 Department of Surgery, Harvard Medical School, Transplantation Research Center, Beth Israel Deaconess Medical Center, Boston, MA 02215
3 Boston University Medical Center, Boston, MA 02118
4 Department of Medicine, University of Virginia, Charlottesville, VA 22908
5 Department of Neurology, Center for Neurological Diseases, Brigham and Women's Hospital, Boston, MA 02115

CORRESPONDENCE Terry B. Strom: tstrom{at}bidmc.harvard.edu OR Simon C. Robson: srobson{at}bidmc.harvard.edu

The study of T regulatory cells (T reg cells) has been limited by the lack of specific surface markers and an inability to define mechanisms of suppression. We show that the expression of CD39/ENTPD1 in concert with CD73/ecto-5'-nucleotidase distinguishes CD4+/CD25+/Foxp3+ T reg cells from other T cells. These ectoenzymes generate pericellular adenosine from extracellular nucleotides. The coordinated expression of CD39/CD73 on T reg cells and the adenosine A2A receptor on activated T effector cells generates immunosuppressive loops, indicating roles in the inhibitory function of T reg cells. Consequently, T reg cells from Cd39-null mice show impaired suppressive properties in vitro and fail to block allograft rejection in vivo. We conclude that CD39 and CD73 are surface markers of T reg cells that impart a specific biochemical signature characterized by adenosine generation that has functional relevance for cellular immunoregulation.


S. Deaglio, K.M. Dwyer, and W. Gao contributed equally to this paper.

T.B. Strom and S.C. Robson contributed equally to this paper.

S. Deaglio's present address is Dept. of Genetics, Biology, and Biochemistry and CeRMS, University of Torino Medical School, 10126 Torino, Italy.

This work was presented, in part, at the Keystone Symposium on Regulatory T cells in Vancouver, Canada in February 2007.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Regulatory T cells carry new ID
Hema Bashyam
J. Exp. Med. 2007 204: 1241b. [Full Text] [PDF]

cAMP crosses junctions
Hema Bashyam
J. Exp. Med. 2007 204: 1240b. [Full Text] [PDF]



This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS